GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

America Great Health AAGH · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

About America Great Health

Its shares trade under the ticker AAGH. It has been listed since 18 June 2012. In the fiscal year to 30 June 2024, it reported revenue of $294,700 and a net loss of $1.2m. At that date it held total assets of $323,500 and shareholders' equity of −$5.2m.

America Great Health focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy and regenerational medicine and supplements manufacturing and sales. The company is headquartered in Alhambra, California. The company went IPO on 2012-06-18. The firm is focused on protein and peptide small molecular drugs research and development, diagnostic and medical devices with artificial intelligence (AI) cloud computing, cell therapy, and re-generational medicine and supplement manufacturing and sales. The company is also focused on investing in innovative technologies, integrated with business development in the healthcare ecosystem.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
18 Jun 2012
Employees
7
Head office
1609 W VALLEY BLVD UNIT 338A, ALHAMBRA, CA, 91803
Incorporated in
CA
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Mike WangChairman of the Board, President, Chief Executive Officer, Chief Financial Officer, since 2017$54,000
  • Mr. Peter BrittonDirector
  • Mr. Rex ChangDirector
  • Ms. Aihua GuoDirector$6,199
  • Mr. Jiaxin XueDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • America Great Health develops AI cloud computing medical devices for diagnostics.
  • The company focuses on protein and peptide small molecular drugs research and development.
  • It manufactures and sells supplements in the US healthcare ecosystem.

Weaknesses

  • The company has only 7 full-time employees.
  • It went public in 2012 with limited resources.
  • Alhambra, California is not a major healthcare hub.

Opportunities

  • Expanding AI cloud computing in healthcare diagnostics offers growth.
  • Investing in cell therapy and regenerative medicine can attract investors.
  • The US healthcare market provides opportunities for supplements sales.

Threats

  • Regulatory changes in the US healthcare sector may impact operations.
  • Competition from larger healthcare firms could affect market share.
  • Economic downturns might reduce healthcare spending.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.